Trials / Completed
CompletedNCT02856646
Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 290 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to gather data on patients diagnosed with and treated for classical Hodgkin Lymphoma (cHL). It aims to closely observe how treatment for cHL is rendered, as well as assess the outcome of those treatment options and their impact on quality of life. Additional analyses will also attempt to identify prognostic or predictive biomarkers
Conditions
Timeline
- Start date
- 2016-10-07
- Primary completion
- 2020-09-30
- Completion
- 2020-09-30
- First posted
- 2016-08-05
- Last updated
- 2021-12-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02856646. Inclusion in this directory is not an endorsement.